老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Bone Biologics Corp

0.6980
+0.03795.74%
盘后：0.6969-0.0011-0.16%16:43 EDT
成交量：5,079.00
成交额：3,447.18
市值：228.32万
市盈率：-0.14
高：0.7000
开：0.6610
低：0.6610
收：0.6601
数据加载中...
总览公司新闻公告
2021/04/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/01/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/01/09

重要事件披露

8-K - Current report
2019/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/09/25

重要事件披露

8-K - Current report
2019/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/08/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/07/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/06/28

重要事件披露

8-K - Current report
2019/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/04/16

重要事件披露

8-K - Current report
2019/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/03/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2019/03/25

重要事件披露

8-K - Current report
2018/11/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/09/14

重要事件披露

8-K - Current report
2018/08/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多